Exact Mass: 296.1158
Exact Mass Matches: 296.1158
Found 93 metabolites which its exact mass value is equals to given mass value 296.1158,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Methionyl-Phenylalanine
Methionyl-Phenylalanine is a dipeptide composed of methionine and phenylalanine. It is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis. This dipeptide has not yet been identified in human tissues or biofluids and so it is classified as an Expected metabolite.
Phenylalanylmethionine
Phenylalanylmethionine is a dipeptide composed of phenylalanine and methionine. It is an incomplete breakdown product of protein digestion or protein catabolism. Dipeptides are organic compounds containing a sequence of exactly two alpha-amino acids joined by a peptide bond. Some dipeptides are known to have physiological or cell-signalling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis.
10-Acetoxy-10,11-dihydro-5h-dibenz[b,f]azepine-5-carboxamide
D002317 - Cardiovascular Agents > D026941 - Sodium Channel Blockers > D061567 - Voltage-Gated Sodium Channel Blockers D002491 - Central Nervous System Agents > D000927 - Anticonvulsants D049990 - Membrane Transport Modulators
Ethyl 2-(5-(4-chlorophenyl)pentyl)oxiran-2-carboxylate
D007004 - Hypoglycemic Agents
3-[(3-(2-Carboxyethyl)-4-methylpyrrol-2-YL)methylene]-2-indolinone
Me glycoside, Me ester-3-Deoxy-D-glycero-D-galacto-2-nonulosonic acid, 9CI
4-O-beta-D-Glucopyranosyl-D-xylose|Pyranose-4-O-beta-D-Glucopyranosyl-D-xylose
Me glycoside-alpha-Pyranose-2-O-beta-D-Xylopyranosyl-D-xylose|Me glycoside-alpha-Pyranose-2-O-beta-D-Xylopyranosyl-L-arabinose|Me glycoside-beta-Pyranose-2-O-beta-D-Xylopyranosyl-L-arabinose
3,4-dideoxy-5-O-alpha-D-galactopyranosyl-pentonic acid
Me glycoside-beta-Pyranose-3-O-beta-D-Xylopyranosyl-D-xylose
2-O-alpha-Rhamnopyranosyl-L-arabinose|alpha-Pyranose-2-O-alpha-Rhamnopyranosyl-L-arabinose|beta-Pyranose-2-O-alpha-Rhamnopyranosyl-L-arabinose
Met-phe
A dipeptide formed from L-methionine and L-phenylalanine residues.
Phe-met
A dipeptide formed from L-phenylalanine and L-methionine residues.
6,6-(1,2-phenylene)bis(1,3,5-triazine-2,4-diamine)
Glycyclamide
C78276 - Agent Affecting Digestive System or Metabolism > C29711 - Anti-diabetic Agent > C97936 - Sulfonylurea Antidiabetic Agent
Ethyl 5-(benzyloxy)-1H-pyrrolo[3,2-b]pyridine-2-carboxylate
tert-Butyl 4-(5-formyl-2-thienyl)piperazine-1-carboxylate
(R)-3-(3-Fluoro-4-morpholinophenyl)-5-(hydroxymethyl)oxazolidin-2-one
(2R,3R,4R,5R)-5-(2,6-diaminopurin-9-yl)-2-(hydroxymethyl)-4-methoxyoxolan-3-ol
trimethoxy-[2-(trimethoxysilylmethyl)prop-2-enyl]silane
tert-butyl 4-(4-formyl-1,3-thiazol-2-yl)piperidine-1-carboxylate
4-formyl-N-(3-pyrrolidin-1-ylpropyl)benzenesulfonamide
1H-Indazole-3-carboxylic acid, 6-(phenylmethoxy)-, ethyl ester
8-BENZYLOXY-IMIDAZO[1,2-A]PYRIDINE-2-CARBOXYLIC ACID ETHYL ESTER
Ethyl 4-(4-chloro-1-oxobutyl)-alpha,alpha-dimethylbenzeneacetate
Eslicarbazepine acetate
D002317 - Cardiovascular Agents > D026941 - Sodium Channel Blockers > D061567 - Voltage-Gated Sodium Channel Blockers C78272 - Agent Affecting Nervous System > C264 - Anticonvulsant Agent D002491 - Central Nervous System Agents > D000927 - Anticonvulsants D049990 - Membrane Transport Modulators
Propanedioic acid,2-[2-(phenylthio)ethyl]-, 1,3-diethyl ester
tert-butyl 7-fluoro-6-nitro-3,4-dihydro-1H-isoquinoline-2-carboxylate
deuterio 2-[2-[bis(2-deuteriooxy-2-oxoethyl)amino]ethyl-(2-deuteriooxy-2-oxoethyl)amino]acetate
1-Ethyl-2,3-dimethylimidazolium tosylate [EDiMIM] [TOS]
4-[4-(4-methoxyphenyl)-5-methyl-1H-pyrazol-3-yl]benzene-1,3-diol
1H-Pyrimido[1,2-a]quinoline-2-carboxylic acid, 1-oxo-, butyl ester
[2-Hydroxy-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropyl] acetate
beta-L-arabinofuranosyl-(1->2)-1-O-methyl-beta-L-arabinofuranose
3-[4-methyl-2-[(E)-(2-oxo-1H-indol-3-ylidene)methyl]-1H-pyrrol-3-yl]propanoic acid
N-(2,3-dihydro-1H-inden-5-yl)-2-methyl-3-nitrobenzamide
2-[3-(3-Methoxyphenyl)-1-indazolyl]acetic acid methyl ester
4-Methoxy-6-[5-(4-methoxyphenyl)-1,2-dihydropyrazol-3-ylidene]-1-cyclohexa-2,4-dienone
4-[(2-fluorophenyl)diazenyl]-1-phenyl-1H-pyrazole-3,5-diamine
1-acetyl-N-propyl-3,4-dihydro-2H-quinoline-6-sulfonamide
6-{[4-(Hydroxymethyl)-5-methyl-2,6-dioxohexahydropyrimidin-5-YL]methyl}-5-methylpyrimidine-2,4(1H,3H)-dione
3-(4-Chlorophenyl)-2-methyl-3,3a,4,5-tetrahydrobenzo[g]indazole
N-(1-cyanocyclohexyl)-2-oxo-1-benzopyran-3-carboxamide
Phe-Met zwitterion
A dipeptide zwitterion obtained by transfer of a proton from the carboxy to the amino terminus of Phe-Met.
4,9-dihydroxy-1-(3-methylbut-2-en-1-yl)phenazin-5-ium-5-olate
1-o-glucopyranosylglycerol; beta-d-(2r)-form,3-ac
{"Ingredient_id": "HBIN002917","Ingredient_name": "1-o-glucopyranosylglycerol; beta-d-(2r)-form,3-ac","Alias": "NA","Ingredient_formula": "C11H20O9","Ingredient_Smile": "NA","Ingredient_weight": "296.27","OB_score": "NA","CAS_id": "92122-76-4","SymMap_id": "NA","TCMID_id": "NA","TCMSP_id": "NA","TCM_ID_id": "9125","PubChem_id": "NA","DrugBank_id": "NA"}
